Rab27a Regulates the Peripheral Distribution of Melanosomes in Melanocytes by Hume, Alistair N. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2001/02/795/14 $5.00
The Journal of Cell Biology, Volume 152, Number 4, February 19, 2001 795–808
http://www.jcb.org/cgi/content/full/152/4/795 795
 
Rab27a Regulates the Peripheral Distribution of Melanosomes
 
in Melanocytes
 
J
 
Alistair N. Hume,* Lucy M. Collinson,
 
‡
 
 Andrzej Rapak,* Anita Q. Gomes,* Colin R. Hopkins,
 
‡
 
 
and Miguel C. Seabra*
 
*Cell and Molecular Biology Section, Division of Biomedical Sciences and 
 
‡
 
Department of Biochemistry, Imperial College of Science, 
Technology and Medicine, London SW7 2AZ, United Kingdom
 
Abstract. 
 
Rab GTPases are regulators of intracellular
membrane trafﬁc. We report a possible function of
Rab27a, a protein implicated in several diseases, includ-
ing Griscelli syndrome, choroideremia, and the Her-
 
mansky-Pudlak syndrome mouse model, 
 
gunmetal
 
. We
studied endogenous Rab27a and overexpressed en-
hanced GFP-Rab27a fusion protein in several cultured
melanocyte and melanoma-derived cell lines. In pig-
mented cells, we observed that Rab27a decorates me-
lanosomes, whereas in nonpigmented cells Rab27a
colocalizes with melanosome-resident proteins. When
dominant interfering Rab27a mutants were expressed
in pigmented cells, we observed a redistribution of pig-
ment granules with perinuclear clustering. This pheno-
type is similar to that observed by others in melano-
cytes derived from the 
 
ashen
 
 and 
 
dilute
 
 mutant mice,
which bear mutations in the 
 
Rab27a
 
 and 
 
MyoVa
 
 loci,
respectively. We also found that myosinVa coimmuno-
precipitates with Rab27a in extracts from melanocytes
and that both Rab27a and myosinVa colocalize on the
cytoplasmic face of peripheral melanosomes in wild-
type melanocytes. However, the amount of myosinVa in
melanosomes from Rab27a-deﬁcient 
 
ashen
 
 melano-
cytes is greatly reduced. These results, together with re-
cent data implicating myosinVa in the peripheral cap-
ture of melanosomes, suggest that Rab27a is necessary
for the recruitment of myosinVa, so allowing the pe-
ripheral retention of melanosomes in melanocytes.
Key words: Rab27a • GTP-binding proteins • vesicu-
lar transport • melanosome • myosinVa
 
Introduction
 
Rab proteins are GTPases that control intracellular vesicu-
lar transport (Novick and Zerial, 1997; Chavrier and Goud,
1999). Rabs form the largest family within the Ras super-
 
family, as 
 
.
 
50 members have been recognized in mamma-
lian cells to date (Pereira-Leal and Seabra, 2000). Many
Rabs have a characteristic subcellular localization and are
proposed to regulate specific steps in intracellular traffick-
ing. The best characterized function of Rabs is to promote
docking and fusion of vesicles between specific pairs of vesi-
cle donor and organelle acceptor membranes (Novick and
Zerial, 1997; Schimmöller et al., 1998). This function seems
to be accomplished by recruitment of tethering factors, an
apparently diverse group of proteins that bring the transport
vesicle into close proximity to the acceptor membrane (Pfef-
fer, 1999). There is also evidence to support their involve-
ment in vesicle formation (for review see Woodman, 1998).
 
Recently, several studies have suggested that Rabs also
interact with cytoskeletal elements and influence the
movement of intracellular membrane vesicles and tu-
bules. A direct interaction between Rab6 and Rab-
kinesin6, a kinesin-like molecule, may stimulate the
movement of Golgi retrograde transport vesicles towards
 
the plus-end of microtubules, i.e.,
 
 
 
to the periphery of the
cell where they fuse with ER membranes (Echard et al.,
1998). In budding yeast, activation of Sec4p by the gua-
nine nucleotide exchange factor Sec2p appears to be an
important step, allowing the movement of secretory vesi-
cles along the polarized actin cytoskeleton towards the
daughter bud (Walch-Solimena et al., 1997). Overexpres-
sion of Rab8 results in changes in cell shape and rear-
rangement of both the actin and microtubule cytoskele-
ton (Peranen et al., 1996), whereas Rab5 is proposed to
promote the motility of early endosomes on microtu-
bules (Nielsen et al., 1999). Finally, Rab3d may regulate
the actin coating of zymogen granules in the exocrine
pancreas and thereby facilitate their movement across
the subapical actin cytoskeleton towards the site of exo-
cytosis (Valentijn et al., 2000).
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Some Rabs such as Rab1 and Rab5 are ubiquitous and
function in common steps in the exocytic and endocytic
pathways of all mammalian cells. Other Rabs appear more
tissue restricted, suggesting a more specialized function.
The Rab27 proteins are an example of the latter. Rab27a
is enriched in eye, platelets, skin, lung, spleen, intestine,
and pancreas (Seabra et al., 1995; Chen et al., 1997). Both
Rab27a and Rab27b isoforms were isolated from melano-
cyte, platelet, and megakaryocyte cells, suggesting an im-
portant function in these cell types and in diseases that af-
fect them (Nagata et al., 1990; Seabra et al., 1995; Chen et
al., 1997). One of these diseases, manifested by partial al-
binism and hemorrhagic disease, is Hermansky-Pudlak
syndrome (HPS)
 
1
 
 (Shotelersuk and Gahl, 1998; Spritz,
2000). HPS may be caused by defects in the biogenesis/
maturation/secretion of specialized organelles of common
endolysosomal origin, such as the melanosomes in me-
lanocytes and the dense granules in platelets (Jackson,
1997; Swank et al., 1998).
Melanocytes reside in the basal level of the epidermis at
the base of hair follicles and possess many long dendrites
that allow intercellular transport of pigment containing
melanosomes from the cell body, the site of synthesis, to
surrounding keratinocytes (for review see Jackson, 1994).
Melanosomes are related to lysosomes, as both are acidic
and thought to contain lysosome-associated membrane
protein (LAMP) family proteins (Orlow et al., 1993).
However, melanosomes may be characterized morpholog-
ically on the basis of their ellipsoidal appearance and in-
ternal membrane striations, and biochemically due to the
presence of matrix proteins (e.g., silver protein/Pmel17/
gp100) and enzymatic proteins (e.g., tyrosinase and ty-
rosine-related protein 1 [TRP-1]/gp75) (Orlow et al., 1993;
Lee et al., 1996). The biogenesis/maturation of melano-
somes in melanocytes is divided into four stages, each with
distinct morphological and biochemical characteristics (for
review see Jimbow et al., 2000). In summary, structural
and enzymatic proteins of the melanosome are processed
through the ER and Golgi and sorted into coated vesicles
at the TGN. Sorting is believed to be mediated by the
adaptor protein complex (AP-3) that interacts with dileu-
cine, targeting motifs located in the cytoplasmic COOH-
terminal tails of these proteins (Vijayasaradhi et al., 1995;
Honing et al., 1998; Calvo et al., 1999). Vesicles are then
transported to spherical vacuoles, termed stage I melano-
somes, which resemble late endosomes at the molecular
level. Stage I structures contain proteinaceous material,
incomplete lamellae, and small vesicles which mature to
form elliptical (eumelanosomes containing black pigment)
or spherical (pheomelanosomes containing yellow pig-
ment) stage II melanosomes in which lamellae have a
more organized appearance. Stage III melanosomes are
electron dense due to melanin deposition, a process which
eventually results in the amorphous appearance of stage
IV melanosomes. Recent elegant time-lapse microscopic
experiments indicate that mammalian melanosomes un-
dergo long range, bidirectional, microtubule-based trans-
 
port and are retained or captured in peripheral dendrites
by interaction with the actin cytoskeleton via the uncon-
ventional myosin, myosinVa (Wu et al., 1998; Rogers and
Gelfand, 2000). Transport to and retention of melano-
somes at the tips of dendrites is essential for their transfer
to keratinocytes and hence normal pigmentation.
We found recently that a mouse model of HPS, 
 
gun-
metal
 
 (
 
gm
 
), is caused by a splice site mutation in the Rab
geranylgeranyl transferase (RGGT) 
 
a
 
 subunit (Detter et
al., 2000). This mutation impairs the synthesis of the het-
erodimeric RGGT enzyme and results in 80% reduction
of its activity. Surprisingly, the reduction in RGGT activity
apparently leads to hypoprenylation/dysfunction of se-
lected Rabs in selected tissues, instead of a generalized de-
fect. In platelets, we found that Rab27 is one such Rab,
suggesting that it may play an important role in both the
hemorrhagic disease and the coat color dilution observed
in 
 
gm
 
 mice (Detter et al., 2000). This observation, together
with previous demonstration of high expression of Rab27
in pigmented cells (Seabra et al., 1995; Chen et al., 1997),
led us to study the function of Rab27 in skin melanocytes.
In the present study, we show that Rab27a is present in
melanosomes and we suggest that Rab27a might act to
promote peripheral retention of melanosomes via recruit-
ment of myosinVa.
 
Materials and Methods
 
Plasmid Constructs
 
The cDNA encoding rat Rab27a (Seabra et al., 1995) and canine Rab1a
(Seabra et al., 1992) served as template to generate the dominant negative
mutants Rab27aT23N, Rab27aN133I, and Rab1aN124I, respectively, by
PCR site-directed mutagenesis. These constructs, as well as human Rab5a
(Farnsworth et al., 1994), were subcloned into the pEGFP-C3 vector
(CLONTECH Laboratories, Inc.) and designated pEGFP-Rab27a,
pEGFP-Rab27aT23N, pEGFP-Rab27aN133I, pEGFP-Rab1a, pEGFP-
Rab1aN124I, and pEGFP-Rab5. The resulting plasmids encode fusion
proteins that contain each Rab protein and mutant attached to the COOH
terminus of the enhanced green fluorescent protein (EGFP).
 
Cell Culture and Transfection
 
Melanocyte cell lines, melan-a originated from a black mouse (Bennett et
al., 1987), melan-b from a brown mouse, melan-c from an albino mouse
(Bennett et al., 1989), and the human malignant melanoma cell line
MM96 were kindly provided by Dorothy Bennett, St. George’s Hospital
Medical School, London, UK. The S91/Cloudman melanoma cell line de-
rived from dilute mouse was obtained from the ECACC. Melan-a, melan-b,
and melan-c cells were cultured in RPMI 1640 supplemented with 10%
fetal calf serum, 2 mM glutamine, 0.1 mM 2-mercaptoethanol, 200 nM
PMA (Calbiochem), 100 U/ml penicillin G, and 100 U/ml streptomycin at
37
 
8
 
C with 10% CO
 
2
 
. MM96 cells were cultured in DME supplemented
with 10% fetal calf serum, 2 mM glutamine, 100 U/ml penicillin G, and
100 U/ml streptomycin at 37
 
8
 
C with 5% CO
 
2
 
. S91/Cloudman melanoma
cells were cultured in Ham’s F-10 medium supplemented with 10% fetal
calf serum, 5% horse serum, 2 mM glutamine, 100 U/ml penicillin G, and
100 U/ml streptomycin at 37
 
8
 
C with 5% CO
 
2
 
. Cells for immunofluores-
cence were grown on coverslips for 24 h, transfected using the liposomal
transfection reagent Fugene 6 (Roche) and then fixed 48 h later.
To derive primary cultures, skins from neonatal 
 
ashen
 
 mice (1–3-d-old)
were incubated with 5 ml of bovine trypsin (5 mg/ml in PBSA) for 1 h at
37
 
8
 
C. The epidermis was then peeled from the dermis using forceps,
washed in PBSA, and cut into smaller fragments using a scalpel blade.
Epidermis fragments from each mouse were then placed in 5 ml of me-
dium (described below) containing 5 
 
m
 
g/ml soybean trypsin inhibitor. This
mixture was then aspirated through the nozzle of a 5-ml combitip and the
resulting cell suspension was plated onto a 20% confluent layer of mito-
mycin C–treated Xb2 murine keratinocyte derived feeder cells. Pigmented
melanocytes were apparent 10–14 d after plating. Primary cultures of mu-
 
1
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rine melanocytes were maintained in RPMI 1640 supplemented with 5%
fetal calf serum, 2 mM glutamine, 200 nM PMA, 200 pM cholera toxin
(Calbiochem), 100 U/ml penicillin G, and 100 U/ml streptomycin at 37
 
8
 
C
with 10% CO
 
2
 
.
 
Antibodies
 
Antibodies Q142 and N688 are polyclonal rabbit antibodies directed
against purified human His
 
6
 
-Rab27a (Tolmachova et al., 1999) and rat
His
 
6
 
-Rab27a, respectively. His
 
6
 
-Rab27a, expressed using pET14b vector,
was produced in 
 
Escherichia coli
 
 as described previously (Seabra et al.,
1995). Rabbits were immunized with 150 
 
m
 
g of purified His
 
6
 
-Rab27a and
immune bleeds were collected as described previously (Seabra et al.,
1991). Anti-Rab27a antibodies were affinity purified from serum using the
respective antigen cross-linked to AminoLink coupling gel (Pierce and
Warriner), as described previously (Seabra et al., 1995). Q142 was used at
1:100 dilution for immunofluorescence and 1:1,000 dilution for immuno-
blotting. Anti-Rab27a mouse monoclonal antibody 4B12 directed against
rat His
 
6
 
-Rab27a was produced as described (Herz et al., 1990) and used at
1 
 
m
 
g/ml for immunoblotting. Other antibodies were used at the following
dilutions: monoclonal antibodies Mel-5 clone Ta99 anti–TRP-1 antibody
(ID Labs) (1:50) and HMB-45 (Dako) reactive against melanosome-resi-
dent protein silver/Pmel17/gp100 (1:50); polyclonal antibodies antical-
nexin (1:10,000), anti-Rab5 (both StressGen Biotechnologies) (1:1,000),
anti-Rab6 (Autogenbioclear) (1:500), anti-Rab8 (Transduction Laborato-
ries) (1:1,000), antityrosinase (1:1,000) (-PEP7 generously provided by Dr.
V. Hearing, National Institutes of Health, Bethesda, MD), antitransferrin
receptor (1:1,000 for immunoblotting and 1:100 for immunofluorescence;
Zymed Laboratories), and antimyosinVa, generously provided by C. Li-
onne and J. Kendrick-Jones (Medical Reasearch Council Laboratory for
Molecular Biology, Cambridge, UK; 1:5,000 for immunoblotting and 1:100
for immunofluorescence). Anti-Rab escort protein (REP)1 J905 (Shen
and Seabra, 1996) and anti-Rab27a N688 polyclonal antibodies were used
for immunoprecipitation.
 
Immunoblotting and Immunofluorescence
 
For immunoblot analysis, samples were subjected to SDS-PAGE and
transferred to polyvinyldifluoride membranes. Membranes were incu-
bated with primary antibody diluted in solution 1 (PBS, 0.2% Tween 20,
5% nonfat dry milk) for 1 h, washed with solution 2 (PBS, 0.2% Tween
20), followed by incubation for 30 min with 1:10,000 dilution of appropri-
ate HRP-conjugated secondary antibody (Dako) diluted in solution 1 and
washing as before. Bound antibody was detected using the ECL system
(Amersham Pharmacia Biotech). Blots were calibrated with prestained
molecular weight standards (Bio-Rad Laboratories). For immunofluores-
cence, coverslip-grown cells were washed in PBS and then fixed in 3%
paraformaldehyde in PBS for 15 min. Excess fixative was removed by ex-
tensive washing in PBS and quenched by incubation in 50 mM NH
 
4
 
Cl for
10 min. Fixed cells were then incubated with primary antibody diluted in
solution 3 (PBS, 0.5% BSA, 0.05% saponin) for 30 min, washed exten-
sively in solution 3, and incubated for 30 min with appropriate Alexa 488–
and/or Alexa 568–conjugated secondary antibodies (Molecular Probes)
diluted in solution 3. Coverslips containing fixed cells were washed as be-
fore in solution 3, mounted in Immuno Fluor medium (ICN Biomedicals),
and observed using a Leica DM-IRBE confocal microscope. Images were
processed using Leica TCS-NT software associated with the microscope
and Adobe Photoshop
 
®
 
 4.0 software. All images presented are single sec-
tions in the z-plane. For simultaneous immunofluorescence using two rab-
bit polyclonal antibodies, fixed cells stained with anti-Rab27a–reactive an-
tibodies were paraformaldehyde fixed for a time after incubation with
Alexa 488–conjugated secondary antibodies. Cells were then incubated
with antimyosinVa antibodies before washing, incubation with Alexa 568–
conjugated anti–rabbit antibodies, and mounting as before. To evaluate
pigment distribution after overexpression of Rab27a, the area of the cyto-
plasm occupied by pigment granules was compared with the total area of
the cytoplasm. Cells in which the area occupied by 90% of the granules
was 
 
#
 
50% of the total were defined as “aggregated” in Table I.
 
Electron Microscopy
 
For ultrathin section preparations, melan-a melanocytes were loaded with
fluid phase HRP at 37
 
8
 
C for 60 min. Compartments of the endocytic path-
way were then cross-linked with DAB and H
 
2
 
O
 
2
 
 and the cells were per-
meabilized with digitonin, all as described previously (Gibson et al., 1998).
The cells were labeled for Rab27a with antibody Q142 (1:50), which was
detected using a 10-nm gold-conjugated secondary antibody. Finally, cells
 
were fixed in 2% paraformaldehyde/1.5% gluteraldehyde, embedded in
Epon, and prepared for thin section electron microscopy.
For whole mount preparations, melan-a and 
 
ashen
 
 melanocytes were
loaded with fluid phase HRP and cross-linked as described above. Cells
were permeabilized with 1% Triton X-100 as described previously (Gib-
son et al., 1998) and labeled for myosinVa with the rabbit polyclonal pri-
mary antibody (1:40) and a 15-nm gold-conjugated secondary antibody
and Rab27a with the mouse monoclonal 4B12 antibody (1:40) detected
with a 10-nm gold-conjugated secondary antibody. Cells were fixed with
4% gluteraldehyde, osmicated, and critical-point dried. Samples were
then rotary-shadowed and carbon-coated and sections were placed on
grids for subsequent electron microscopy.
 
Subcellular Fractionation
 
Cultured melanocytes were washed twice with 10 mM Tris-HCl, pH 7.5,
150 mM NaCl, 5 mM MgCl
 
2
 
 and scraped in the same buffer containing
10 g/ml of aprotinin, leupeptin, pepstatin, 0.5 mM PMSF, and 1 mM
DTT. Cells were homogenized in buffer containing 10 mM Hepes, pH
7.2, 1 mM EDTA, 0.25 M sucrose and protease inhibitors, by five pas-
sages through a cell cracker (EMBL). Nuclei were pelleted by centrifu-
gation at 100 
 
g
 
 for 10 min before the postnuclear supernatant was frac-
tionated using a Percoll gradient as described previously (Orlow et al.,
1993). In brief, the postnuclear supernatant was mixed with 90% Percoll
in 0.25 M sucrose buffer to a final concentration of 28% Percoll and the
mixture was centrifuged in a Vti 65.2 rotor (Beckman Coulter) for 48
min at 10,000 
 
g
 
 at 4
 
8
 
C. Fractions (250 
 
m
 
l) were collected from the top of
the gradient and centrifuged for 60 min at 100,000 
 
g
 
 to remove Percoll
before gel electrophoresis.
 
Immunoprecipitation
 
Melan-a and melan-b cells grown on 15-cm dishes to 80% confluency were
washed three times with cold PBS, scraped, and harvested by centrifuga-
tion. Cell pellets or eye tissue, after removal of the lens from C57Bl6/J
mice, were then lyzed in buffer containing 20 mM Tris-HCl, pH 7.5, 50
mM NaCl, 1 mM EGTA, 1% CHAPS, 10 
 
m
 
g/ml each of aprotinin, leu-
peptin, and pepstatin, and 0.5 mM PMSF. Lysates were centrifuged at
10,000 
 
g
 
 for 15 min and the supernatant was then incubated with poly-
clonal antibodies (1 
 
m
 
g) previously immobilized on protein A–Sepharose.
After overnight incubation at 4
 
8
 
C, the beads were precipitated by low
speed centrifugation, washed four times with the same buffer, and boiled
in SDS sample buffer. Precipitated proteins were separated on 4–15% gra-
dient SDS polyacrylamide gel, transferred to polyvinyldifluoride mem-
brane, and immunoblotted as described above.
 
Online Supplemental Material
 
Online supplemental materials can be found at http://www.jcb.org/cgi/
content/full/152/4/795/DC1.
Figure S1 shows low power images of fields of melan-c melanocytes la-
beled with anti-Rab27a antibodies taken using a 203 objective lens. It
shows that Rab27a was typically distributed in 0.5-mm-diameter structures
located in the peripheral cytoplasm and dendrites, which contain TRP-1
and silver protein, as well as diffuse cloudy pattern close to the nucleus.
In Figure S2, to ensure the specificity of binding of the Alexa 568–conju-
gated goat anti–rabbit secondary antibody used to detect antimyosinVa in
Fig. 6, we incubated melan-c cells already stained for Rab27a using polyclonal
antibodies (detected using Alexa 488–conjugated goat anti–rabbit secondary
antibodies) with Alexa 568–conjugated goat anti–rabbit secondary antibody
alone. We found that almost no Alexa 568–conjugated goat anti–rabbit sec-
ondary antibody bound to cells in the absence of the antimyosinVa polyclonal
antibody (Figure S2 E).
 
Table I. Overexpression of Dominant Interfering Mutants of 
Rab27a in Melan-a Cells Induces Aggregation of 
Melanosomes Close to the Nucleus
 
Transfected DNA Percent dispersed Percent aggregated
 
pEGFPRab27a 100 0
pEGFPRab27aT23N 87 13
pEGFPRab27aN133I 19 81
pEGFPRab1aN124I 100 0
 
n
 
 
 
5 
 
100. 
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Figure 1. Rab27a colocalizes with melanosome-resident proteins in MM96 and melan-c cells. Coverslip-grown melan-c or MM96
cells were fixed and stained using the polyclonal anti-Rab27a antibody Q142 (A, D, G, and J); monoclonal antibodies reactive to the
melanosomal marker proteins TRP-1 (B) or silver (E and H); and the transferrin receptor (Tfn; panel K), an endosome marker, as
described in Materials and Methods. Polyclonal antibodies were detected using Alexa 488–conjugated goat anti–rabbit secondary an-
tibodies (A, D, G, and J); monoclonal antibodies were detected using Alexa 568–conjugated goat anti–mouse second antibodies (B,
E, H, and K). Merged fluorescent signals for Rab27a and the indicated marker proteins are shown in C, F, I, and L. Bar, 10 mm. See
Figure S1, available at http://www.jcb.org/cgi/content/full/152/4/795/DC1. 
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Results
 
Colocalization of Rab27a with Melanosomes
 
We first confirmed that Rab27a protein is highly expressed in
melanocytes. We immunoblotted detergent lysates of several
cultured cell lines using an affinity-purified rabbit polyclonal
anti–human Rab27a antibody, Q142. This antibody was
highly specific for Rab27a and did not cross-react with
Rab27b or any other Rab proteins tested (data not shown).
We observed high levels of Rab27a expression in nonpig-
mented melanocytic cell lines, melan-c and MM96, lower lev-
els of Rab27a expression in pigmented cell lines, melan-a and
melan-b, and only very low levels of expression of Rab27a in
several different cultured fibroblast cell lines (data not
shown). These data are consistent with an earlier report of
the expression of the Rab27a mRNA and demonstrate the
specificity of the anti-Rab27a antibody (Chen et al., 1997).
 
The finding that Rab27a is highly expressed in melano-
cyte and melanoma-derived cells suggested that Rab27a
might be associated with a transport pathway or organelles
specific to melanocytes. We then examined the subcellular
localization of the protein by immunofluorescence micros-
copy in nonpigmented melan-c melanocytes, derived from
an albino mouse that lacks tyrosinase activity, and the hu-
man melanoma–derived cell line MM96 (Fig. 1). In melan-c
and MM96 cells, the Q142 antibody revealed that Rab27a
primarily localizes to peripheral organelles (
 
z
 
0.5 
 
m
 
m in di-
ameter) (Fig. 1, A, D, G, and J). In most cases, peripheral
Rab27a-positive structures also contained melanosome-
resident proteins: TRP-1 (Fig. 1, A–C) and silver protein/
Pmel17/gp100 (HMB-45) (Fig. 1, D–I). Electron micros-
copy indicated that these structures are melanosomes, as
they contained a fibrillar core but lacked melanin (data not
shown). In MM96 cells, we observed a similar pattern.
Rab27a is distributed on linear structures extending from
Figure 2. Transiently overexpressed EGFP-Rab27a is associated with pigment granules in melan-a cells. Melan-a cells were transfected
with pEGFP-Rab27a (A–H) or pEGFP-Rab5 (I–L) and fixed 48 h later, as described in Materials and Methods with the following mod-
ification. After transfection, cells were permeabilized for 5 min before fixation in solution 4 (80 mM K-Pipes, pH 6.8, 5 mM EGTA, 1
mM MgCl2, 0.05% saponin) in order to remove nonmembrane-associated fusion protein. A, E, and I show the distribution of the indi-
cated overexpressed EGFP-Rab fusion protein in melan-a cells. B, F, and J are phase–contrast images of melan-a cells showing the dis-
tribution of pigment granules in transfected cells. Phase–contrast images (B, F, and J) of melan-a cells were transformed into pseudo-
color (red) images, shown in C, G, and K, using Adobe Photoshop® 4.0 and then merged with the green fluorescence signal emitted by
overexpressed EGFP-Rab27a or EGFP-Rab5 proteins, respectively (D, H, and L). Bars, 10 mm. 
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the cell body into the peripheral dendrites (Fig. 1 J). We
also observed partial colocalization of Rab27a with the ly-
sosome-resident LAMP-1 (data not shown), which also as-
sociates with melanosomes (Orlow et al., 1993). In many
cells we observed a diffuse, cloudy pattern Rab27a staining
close to the nucleus (Fig. 1, D and G). This pattern could
correspond to small Rab27a-containing membrane vesicles
rather than cytosolic protein, as immunoblotting of S100
fractions prepared from the same cells were devoid of
Rab27a (data not shown). Staining of these cells with anti-
bodies reactive to proteins resident in other compartments
of the secretory and endocytic pathways (Fig. 1, J–L, and
data not shown) suggests that little Rab27a associates with
another identifiable membrane-bound organelle.
We next sought to extend these observations by tran-
sient overexpression of EGFP-Rab27a fusion protein. Pre-
vious reports indicate that attachment of EGFP to the NH
 
2
 
terminus of other Rab proteins does not affect targeting of
the resulting EGFP-tagged Rab proteins relative to their
nontagged counterparts (Roberts et al., 1999; White et al.,
1999). We observed that EGFP-Rab27a fusion protein was
distributed mainly in the periphery of pigmented melan-a
(Figs. 2, A–H) and melan-b (data not shown) cells forming
ring-like patterns. Close examination indicates that many
of the rings of EGFP-Rab27a appear to surround pigment
granules, suggesting that Rab27a decorates the cytoplas-
mic surface of granules. We also observed significant colo-
calization of overexpressed Rab27a fusions with the me-
lanosome-resident protein tyrosinase in melan-b cells (data
not shown). In contrast, overexpressed EGFP-Rab5 (Fig.
2, I–L), EGFP-Rab1, EGFP-Rab6, and EGFP-Rab8 (data
not shown) fusion proteins did not colocalize with melano-
somes in these cell lines, indicating the specificity of the as-
sociation of the EGFP-Rab27a fusion protein with me-
Figure 3. Immunoelectron
microscopy of Rab27a in
melan-a cells. (A) Melan-a
melanocytes contain pre-
dominantly stage IV melano-
somes, many of which are la-
beled for Rab27a. Melan-a
melanocytes were permeabi-
lized with digitonin and
the anti-Rab27a antibody
detected with a 10-nm gold-
conjugated secondary anti-
body as described in Materi-
als and Methods. The
presence of representative
gold particles is indicated by
arrows. Mitochondria (M)
are demonstrative of other
organelles in the melanocyte
that show a very low level of
background labeling. (B)
Rab27a-positive melano-
somes lie just below the
plasma membrane (PM) ad-
jacent to a clathrin-coated
vesicle (CCV). Bars, 0.5 mm. 
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lanosomes. Together these results suggest that endogenous
and overexpressed Rab27a protein may be associated with
the limiting membrane of melanosomes.
To substantiate light microscopic observations, we then
used immunoelectron microscopy to examine the localiza-
tion of endogenous Rab27a in melan-a cells, which con-
tain mostly late stage melanosomes. Cells were perme-
abilized to give access to the cytoplasmic face of the
perimeter membrane of the organelles and then incubated
with anti-Rab27a antibody. As shown in Fig. 3, Rab27a la-
beled melanosomes, most of which were late stage struc-
tures (i.e., stage IV), as indicated by their electron-dense
appearance and ellipsoid shape. The gold label appeared
to be distributed over the surface of the limiting mem-
brane of melanosomes, as indicated in Fig. 3 B. Labeled
melanosomes were often distributed in the vicinity of the
plasma membrane, whereas other membrane-bound or-
ganelles, such as lysosomes and multivesicular endo-
somes, were unlabeled.
 
Subcellular Fractionation Confirms the Association of 
Rab27a with Melanosomes
 
To confirm our morphological observations, we subjected
melan-a cellular membranes to ultracentrifugation in a
Percoll gradient under conditions which separate melano-
somes from other cellular membranes due to their high
density (Orlow et al., 1993). Immunoblotting of gradient
fractions revealed that most Rab27a is present in two
peaks (Fig. 4). One peak (fractions 15–18) corresponded
to relatively dense membrane fractions, which contained a
significant amount of tyrosinase and melanin, but not cal-
nexin (a marker of the ER), Rab6 (a marker of Golgi vesi-
cles), transferrin receptor and Rab5 (markers of endo-
somes), or Rab8 (a marker of post-Golgi vesicles) (Fig. 4).
The lighter (earlier) fractions seem to include most of the
other cellular membranes as they contained calnexin,
Rab6, transferrin receptor, Rab5, and Rab8. In summary,
subcellular fractionation confirms the presence of Rab27a
on melanosomes.
 
Overexpression of Dominant Negative Rab27a Mutants 
Causes Alteration in the Distribution of Melanosomes 
in Cultured Melanocytes
 
To address the function of Rab27a in cultured melano-
cytes, we attempted to disrupt its function by transi-
ent overexpression of Rab27a mutants, Rab27aT23N
and N133I, equivalent to the dominant interfering
RasS17N and N116I mutants, respectively. Transient over-
expression of many other Rabs containing corresponding
changes has been shown to specifically disrupt the func-
tion of the endogenous protein (e.g., Walworth et al.,
1989). The RasS17N and N116I mutants bind to guanine
nucleotide exchange factors with higher affinity than
wild-type Ras, thereby preventing activation of the wild-
type protein (Feig, 1999). The Rab mutants are believed
to act similarly.
Transient overexpression experiments revealed that EGFP-
Rab27aT23N and EGFP-Rab27aN133I fusion proteins were
predominantly cytosolic and that their expression (Fig. 5,
E–L), but not the wild-type (Figs. 2, A–H and 5, A and B) or
the constitutively active mutant Rab27aQ78L (not shown),
resulted in dramatic redistribution of pigment granules in
melan-a cells. In cells expressing either of the dominant inter-
fering mutants, pigment granules are observed to cluster
close to the nucleus (Fig. 5, E–L) in contrast to nontrans-
fected cells and those transfected with wild-type EGFP-
Rab27a in which pigment granules are distributed evenly
throughout the cytoplasm (Figs. 2, B and F, and 5 B). Simi-
lar effects on granule positioning were induced by overex-
pression of nontagged and myc-tagged Rab27aT23N and
Rab27aN133I mutants, and with another pigmented cell
line, melan-b (data not shown). We also found that the
Rab27aT23N and Rab27aN133I mutants differ in their abil-
ity to cause perinuclear clustering of melanosomes, their ex-
pression resulting in this phenomenon in 13 and 81% of
transfectants, respectively (Table I). This result corresponds
with previous studies suggesting that the Ras-equivalent
N116I mutant elicits a stronger dominant negative effect than
the S17N mutant, as we could not detect significant differ-
Figure 4. Subcellular fractionation of
melanocyte-derived membranes. Post-
nuclear supernatants of melan-a cells
were subjected to a 28% Percoll gradi-
ent centrifugation; fractions were then
collected from the top of the gradient
and analyzed by immunoblot. The
lightest fraction is 1 (top of the gradi-
ent) and the densest fraction is 18 (bot-
tom of the gradient). Antibodies used
are indicated on the right. Rab5, Rab6,
and Rab8 localize to early endosomes,
Golgi, and TGN/plasma membrane,
respectively. Calnexin, the transferrin
(Tfn) receptor, and tyrosinase are
membrane proteins that localize to the
ER, early endosomes, and melano-
somes, respectively. 
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ences between the levels of mutant protein expressed (Tis-
dale et al., 1992). We never observed this effect in wild-type
Rab27a transfected cells or in cells transfected with EGFP-
Rab1, EGFP-Rab1aN124I (Fig. 5, G and H), EGFP-Rab5
(Fig. 2, I–L), EGFP-Rab6, or EGFP-Rab8 (data not shown).
Interestingly, the distribution of pigment granules in me-
lanocytes overexpressing Rab27a dominant negative mutants
is very similar to that observed after expression of dominant
negative myosinVa constructs (Wu et al., 1998). Further-
more, the results of recent studies suggest that myosinVa par-
ticipates in the retention of melanosomes in the periphery of
melanocytes (for review see Rogers and Gelfand, 2000), sug-
gesting that Rab27a and myosinVa cooperate in establishing
and/or maintaining the peripheral distribution of melano-
somes in melanocytes. The finding that a proportion of myo-
sinVa is present on melanosomes in melanocytes also sup-
ports this idea (Nascimento et al., 1997; Wu et al., 1997).
 
Rab27a Colocalizes with
Melanosome-associated MyosinVa
 
To test the possible functional interaction of melano-
some-associated Rab27a and myosinVa, we investigated
whether the two proteins exhibit similar patterns of intra-
cellular distribution. We did this using two approaches.
First, we employed immunofluorescence microscopy to
examine the extent of colocalization of endogenous myo-
sinVa with either transiently overexpressed EGFP-Rab27a
or endogenous Rab27a in nonpigmented melan-c and
MM96 cells (Fig. 6 and data not shown). We observed a
high level of coincidence in the distribution of both over-
expressed and endogenous Rab27a with endogenous myo-
sinVa in melan-c and MM96 cells (Fig. 6 and data not
shown). Cytoplasmic structures (0.5-
 
m
 
m diameter) con-
taining Rab27a and myosinVa were defined as melano-
somes by staining with anti–TRP-1 antibodies (data not
shown). The subcellular distribution of Rab27a in these
cells appears to coincide more closely with that of myo-
sinVa than with that of the melanosome-resident proteins
examined above (compare Fig. 6 with Figs. 1 and 2). In-
terestingly, immunoblotting revealed that nonpigmented
cells, melan-c and MM96, express higher levels of myo-
sinVa relative to the pigmented melanocytes melan-a and
melan-b, as found for Rab27a (data not shown).
To examine more precisely the proximity of endogenous
melanosome-associated Rab27a and myosinVa, we per-
formed double immunoelectron microscopy of melan-a
cells using ultrathin and whole mount preparations (Fig.
7). Clusters of Rab27a (10-nm gold) and myosinVa (15-nm
Figure 5. Transient overexpression of dominant interfering Rab27a mutants, Rab27aT23N and Rab27aN133I, results in perinuclear
clustering of pigment granules in melanocytes. Melan-a cells were transfected with pEGFP-Rab27a (A and B), pEGFP-Rab1aN124I (C
and D), pEGFP-Rab27aT23N (E–H), or pEGFP-Rab27aN133I (I–L) and fixed 48 h later, as described in Materials and Methods. A, C,
E, G, I, and K show the distribution of the indicated overexpressed EGFP-Rab fusion protein in melan-a cells. B, D, F, H, J, and L are
phase–contrast images showing the distribution of pigment granules in these cells. Bars, 10 mm. 
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Figure 6. MyosinVa colocalizes with Rab27a on melanosomes in wild-type melanocytes, but is absent from melanosomes in Rab27a
mutant ashen melanocytes. (A–F) Melan-c cells were transfected with pEGFP-Rab27a (A) and fixed 48 h later. Endogenous Rab27a in
fixed melan-c cells was stained using the polyclonal anti-Rab27a antibody Q142 detected using Alexa 488–conjugated goat anti–rabbit
antibodies (D). Residual bound anti-Rab27a antibody, not detected by the Alexa 488–conjugated goat anti–rabbit antibodies, was then
destroyed by a second round of fixation (see Materials and Methods). Transfected or anti-Rab27a–stained cells were then stained for
myosinVa using polyclonal antimyosinVa antibody detected using Alexa 568–conjugated goat anti–rabbit antibodies (B and E). (G–I)
Coverslip-grown primary cultures of melanocytes derived from the murine Rab27a mutant ashen were fixed and stained with antimyo-
sinVa polyclonal antibodies and anti–TRP-1 monoclonal antibodies which were detected using Alexa 488–conjugated goat anti–rabbit
antibodies (H) and Alexa 568–conjugated goat anti–mouse antibodies (I). G is a phase–contrast image showing the perinuclear distribu-
tion of melanosomes in ashen melanocytes. (J–L) Coverslip-grown S91/Cloudman melanoma cells derived from the murine myosinVa
mutant dilute were fixed and stained with polyclonal anti-Rab27a antibody and monoclonal HMB-45 antibody detected using Alexa
488–conjugated goat anti–rabbit antibodies (J) and Alexa 568–conjugated goat anti–mouse antibodies (K). C, F, and L show merged
fluorescence images. Bars, 20 mm. See supplemetal figure S2, available at http://www.jcb.org/cgi/content/full/152/4/795/DC1. 
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gold) were observed on the perimeter membrane of me-
lanosomes in ultrathin sections of permeabilized melan-a
cells (Fig. 7 A). Whole mount preparations (Fig. 7, B and
C) were made in order to gain an overview of the myo-
sinVa content of the cell while preserving the actin cyto-
skeleton. MyosinVa is abundant within melan-a melanocytes
and is localized on material attached to the actin cytoskele-
ton as well as over the surface membrane of melanosomes,
often at sites in which the melanosomes and cytoskeletal
filaments lie in close proximity. The whole mount confirms
the partial colocalization of Rab27a and myosinVa at the
cytoplasmic face of melanosomes (Fig. 7 B) and the associ-
ation of these gold labels with cytoskeletal elements.
 
Rab27a May Be Required for the Association of 
MyosinVa with Melanosomes
 
To investigate further the possible functional interplay be-
tween Rab27a and myosinVa, we asked whether one role
of Rab27a might be to mediate the association of myo-
sinVa with melanosomes. To address this possibility, we
employed immunofluorescence and immunoelectron mi-
croscopy to investigate the subcellular localization of myo-
Figure 7. Localization of myosinVa in melan-a and ashen melanocytes. Myo-
sinVa (15-nm gold) and Rab27a (10-nm gold) were colocalized in Epon-
embedded ultrathin sections (A) and whole mounts (B) of melan-a melano-
cytes as described in Materials and Methods. The distribution of myosinVa in
melan-a melanocytes (C) was compared with the distribution in Rab27a mu-
tant ashen melanocytes (D). Melan-a melanocytes were incubated with the
secondary 15-nm gold anti–rabbit antibody as a control for specificity of the la-
bel. Negligible levels of background labeling were observed (E). Bar, 0.5 mm. 
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sinVa in primary cultures of melanocytes derived from the
skins of 
 
ashen
 
 mutant mice. As discussed below in more
detail, 
 
ashen
 
 mice bear a loss-of-function mutation in the
Rab27a gene (Wilson et al., 2000).
We found that pigment granules in 
 
ashen
 
 melanocytes
cluster close to the nucleus rather than being evenly dis-
tributed in peripheral cytoplasmic locations, as we ob-
served for melan-a and melan-b melanocytes (Figs. 2 and 6
and data not shown). These observations are consistent
with previous reports of the phenotype of melanocytes de-
rived from 
 
dilute 
 
and 
 
ashen
 
 mutants (Provance et al., 1996;
Wilson et al., 2000). When we stained for myosinVa, we
observed that much of the myosinVa in 
 
ashen
 
 melanocytes
is mostly excluded from the melanosome perinuclear
mass. Instead, myosinVa appears concentrated in a clearly
defined spot, which appears to coincide with the microtu-
bule organizing center, as indicated by costaining with
anti–
 
a
 
-tubulin antibodies, and the remainder is distributed
throughout the cytoplasm (Fig. 6 and data not shown).
This contrasts with clear melanosome association of myo-
sinVa in melan-a and melan-c melanocytes (Figs. 6 and 7),
and in primary cultures of melanocytes derived from wild-
type C3H mice (the background strain of the 
 
ashen
 
 mu-
tant) in which myosinVa is abundant on melanosomes
(data not shown). Staining of 
 
ashen
 
 melanocytes with anti-
bodies reactive to other melanosome-resident proteins,
e.g., TRP-1 (Fig. 6 I) and silver (data not shown), con-
firmed that the clustered pigmented structures containing
little myosinVa were indeed melanosomes. Interestingly,
we observe that in 
 
ashen
 
 melanocytes some melanosomes
are present in peripheral dendrites, unlike the majority in
a perinuclear cluster (Fig. 6 G). A similar distribution of
melanosomes was observed in melan-a melanocytes over-
expressing Rab27a dominant negative proteins (Fig. 5)
and in dilute melanocytes or melanocytes expressing dom-
inant negative mutants of myosinVa (Wu et al., 1998).
These peripheral melanocytes may reach the periphery via
microtubule-based transport, as suggested by Wu et al.
(1998). Immunoelectron microscopy data fully confirmed
the immunofluorescence observations. In comparison with
the wild-type melan-a (Fig. 7 C), myosinVa was expressed
 
at a much lower level in 
 
ashen
 
 melanocytes. There were
concentrations of melanosomes in the perinuclear area,
but these were not labeled with myosinVa. Most of the
myosinVa label in these cells was associated with the actin
cytoskeleton (Fig. 7 D).
These data suggest that Rab27a is required for the asso-
ciation of myosinVa with melanosomes in wild-type me-
lanocytes, i.e., that Rab27a functions upstream of myo-
sinVa. One prediction of this hypothesis is that Rab27a
should be targeted to melanosomes in the absence of myo-
sinVa. Therefore, we examined the intracellular location of
Rab27a in the S91/Cloudman melanoma cell line, derived
from dilute (myosinVa mutant) mice (Yasamura et al.,
1966). We observed by immunofluorescence microscopy
that Rab27a was present in punctate cytoplasmic structures
which also contained the melanosome-resident proteins sil-
ver and LAMP-1 (Fig. 6, J–L, and data not shown). These
observations further support the possibility that Rab27a re-
cruits myosinVa to melanosomes in melanocytes.
 
Coimmunoprecipitation of Rab27a and MyosinVa
 
A second prediction of this hypothesis is that Rab27a and
myosinVa interact. Therefore, we examined whether myo-
sinVa can be precipitated from detergent extracts of
cultured murine melanocytes or murine tissues using affin-
ity-purified anti-Rab27a antibodies. We observed that myo-
sinVa is precipitated by anti-Rab27a antibodies in extracts
prepared from melan-a and melan-c cells and mouse eyes
(Fig. 8), but not in those from HeLa cells or mouse brain
where Rab27a is not expressed (data not shown). Precipi-
tation of myosinVa appears specific, as it was absent from
precipitates prepared using anti-REP1 antibodies or pro-
tein A beads (Fig. 8) as well as murine brain extracts in
which Rab27a is undetectable (data not shown; Seabra et
al., 1995; Chen et al., 1997).
 
Discussion
 
The data presented here suggest a possible function for the
Rab27a GTPase in establishing and/or maintaining the pe-
ripheral distribution of melanosomes in melanocytes. Our
results indicate that Rab27a protein is highly expressed in
melanocytes, that Rab27a is associated with melanosomes,
and that overexpression of dominant negative mutants of
Rab27a causes redistribution of melanosomes from the cell
periphery and perinuclear clustering of melanosomes. We
also report that Rab27a and myosinVa colocalize and in-
teract in melanocytes and that Rab27a may recruit myo-
sinVa to melanosomes, as little myosinVa is found on me-
lanosomes in the absence of Rab27a.
We present morphological and biochemical data consis-
tent with the association of Rab27a with melanosome
membranes (Figs. 1–4). First, Rab27a colocalizes with pig-
mented melanosomes in cultured melanocytes (melan-a
and melan-b) by immunofluorescence and immunoelec-
tron microscopy (Figs. 2 and 3). Second, Rab27a colocal-
izes with peripheral structures labeled by melanosome
markers in amelanotic melanocytes (melan-c) and mela-
noma-derived cells (MM96) by immunofluorescence mi-
croscopy (Fig. 1). Third, Rab27a cofractionates with ty-
rosinase, but not other organelle markers in Percoll
gradients of melanocyte membranes (Fig. 4). Rab27a ap-
Figure 8. Coimmunoprecipitation of Rab27a and myosinVa.
Melanocyte or mouse eye lysates were incubated with the indi-
cated antibodies. The adsorbed material was precipitated and an-
alyzed by immunoblot as described in Materials and Methods. 
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pears to reside predominantly in mature melanosomes.
Immunoelectron microscopy shows Rab27a to be associ-
ated predominantly with type III and type IV melano-
somes, whereas the association of Rab27a with type I and
II melanosomes was less evident (Fig. 3; our unpublished
observations).
We also show that overexpression of two independent
dominant negative mutants of Rab27a, but not Rab1a, re-
sults in clustering of melanosomes in the perinuclear area
in two pigmented melanocyte cell lines (Fig. 5 and data not
shown). This suggests that one aspect of Rab27a function
is establishing and/or maintaining the peripheral localiza-
tion of melanosomes in dendritic processes. This possibil-
ity is supported by the fact that melanosomes are clustered
around the nucleus in melanocytes derived from 
 
ashen
 
mice (Fig. 6; Wilson et al., 2000) and Griscelli disease pa-
tients (Bahadoran et al., 2001), both of which were re-
cently found to contain loss-of-function mutations in the
murine and human Rab27a loci, respectively (Menasche et
al., 2000; Wilson et al., 2000). In contrast to the results ob-
tained using dominant negative mutants, we did not ob-
serve enhanced dispersion of melanosomes after overex-
pression of wild-type Rab27a or the GTPase-deficient
mutant (Rab27aQ78L) (Fig. 5 and data not shown). The
vast majority of melanosomes in the cultured mammalian
melanocytes used in this study are already located at the
periphery and contain Rab27a and myosinVa (Figs. 1, 2,
and 6). Hence, their steady-state location is unlikely be al-
tered by overexpression of wild-type or GTPase-deficient
(constitutively active) protein, as this is likely merely to
enhance the interaction between myosinVa and Rab27a
and further stabilize their peripheral retention. However,
we note that fixed cells were used for these studies and
more subtle motility effects may have been missed.
A current model for the transport of melanosomes in
mouse melanocytes is based on the work of Wu et al.
(1998). This model envisages that melanosomes mature in
the melanocyte cell body region, undergo bidirectional
transport along microtubules, which extend into the den-
drites, and are then “captured” and retained in peripheral
regions by interaction with the local actin cytoskeleton via
myosinVa. Consistent with this hypothesis, loss of myo-
sinVa function as observed in the mouse 
 
MyoVa
 
 gene mu-
tant dilute or, due to overexpression of a dominant inter-
fering myosinVa construct, results in accumulation of
melanosomes in the perinuclear region of melanocytes
(Mercer et al., 1991; Provance et al., 1996; Wu et al., 1998).
As it is now clear that Rab27a is also a critical player in
this process, one important question is, how are Rab27a
and myosinVa cooperating in the peripheral capture of
melanosomes?
The current results lead us to hypothesize that Rab27a
recruits myosinVa to melanosomes, thus mediating their
peripheral “capture.” Several lines of evidence support
this possibility. First, Rab27a and myosinVa colocalize to
melanosomes (Figs. 6 and 7). In particular, electron mi-
croscopy indicates that myosinVa and Rab27a are not
evenly distributed over the cytoplasmic surface of melano-
somes, rather both are clustered together in groups whose
location often coincides with that of actin filaments seen in
labeled whole mount sections (Fig. 7, B and C). Second,
significantly less myosinVa is associated with melano-
somes in ashen melanocytes (Rab27a mutant) compared
with wild-type melanocytes (Figs. 6 and 7). Interestingly,
we observed that the association of myosinVa with the
centrosome is more pronounced in ashen melanocytes
than in other mouse melanocytes used in this study or in
primary cultures derived from C3H mice (Fig. 6 and data
not shown). Previous studies have reported the association
of myosinVa with the centrosome via the COOH termi-
nus globular tail of myosinVa (Espreafico et al., 1998;
Tsakraklides et al., 1999). The role for centrosomal myo-
sinVa is unclear. Nevertheless, our studies suggest that
Rab27a is able to influence the distribution of a significant
fraction of the myosinVa cellular pool, which becomes as-
sociated with melanosomes. Third, Rab27a can be tar-
geted to organelles containing melanosomal markers in di-
lute cells (myosinVa mutant), indicating that Rab27a does
not require functional myosinVa for targeting to melano-
somes (Fig. 6). Finally, myosinVa can be coimmunoprecip-
itated from melanocytes and mouse tissues with anti-
Rab27a antibodies, indicating that both proteins interact
(Fig. 8). Precedence for such a mechanism of action for
Rab27a comes from the finding that activation of other
Rab proteins results in specific recruitment of “effector”
proteins, which in each case are thought to mediate the
function of the Rab (Stenmark et al., 1995; Guo et al.,
1999; McBride et al., 1999; Allan et al., 2000).
The precise mechanism by which Rab27a recruits myo-
sinVa to melanosomes remains to be clarified in future
studies. Despite some effort, we have not yet been able to
determine whether the Rab27a and myosinVa interaction
is direct. However, it is possible that the interaction is indi-
rect, as there is genetic evidence that at least one more
gene product is involved in this process. Melanocytes de-
rived from the leaden mutant (whose gene is unknown),
like those derived from ashen and dilute, exhibit perinu-
clear clustering of melanosomes (Provance et al., 1996)
and all three coat color phenotypes are rescued by the di-
lute suppressor mutant (Moore et al., 1988). These obser-
vations suggest that all four proteins act in the same path-
way, perhaps as components of a complex containing
Rab27a and myosinVa. The future isolation of the compo-
nents of the proposed complex, including the products of
the dilute suppressor and leaden loci, may provide impor-
tant clues to the molecular mechanisms regulating or-
ganelle motility in general and melanosome motility in
particular.
Rab27a has also been implicated in two other disease
states involving defects in Rab lipidation and membrane
association. One example is the gm mouse, which led to
the studies presented here (Detter et al., 2000). The coat
color dilution observed in gm may result from dysfunction
of Rab27a in melanocytes, given the evidence discussed
here. Another example is the X-linked human retinal de-
generative disease, choroideremia (CHM) (Seabra et al.,
1995). In CHM, a protein required for the posttransla-
tional geranylgeranylation and membrane association of
Rab proteins, REP1 is mutated (Seabra et al., 1992, 1993).
This defect does not result in a general defect in Rab pre-
nylation in CHM, since REP function is redundant in
mammalian cells and can be compensated by REP2. For
unknown reasons, Rab27a is not a good substrate for
REP2 and is selectively dysfunctional in CHM cells, sug-Hume et al. Rab27a and Melanosome Transport 807
gesting that it may act as a trigger for the retinal degenera-
tion (Seabra et al., 1995). In light of our present data and
that of others (Menasche et al., 2000; Wilson et al., 2000),
it is possible that the retinal phenotype of CHM patients
may result in part from defects in melanosome transport in
the retinal pigmented epithelium and choroid. However, it
is likely that dysfunction of other Rabs may contribute to
this phenotype.
This work strengthens the idea that Rabs could be im-
portant regulators of membrane–cytoskeleton interac-
tions. The regulation of membrane motility may indeed be
a general role for Rabs, in addition to their more estab-
lished role in transport vesicle docking. Future work
should be directed towards a more detailed molecular de-
scription of Rab27a function in melanocytes.
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